Back to search
Rhegmatogenous Retinal Detachment
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Rhegmatogenous Retinal Detachment trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Rhegmatogenous Retinal Detachment trials you may qualify forThis study aims to determine if one day post-operative prone head positioning can be as good as seven days post-operative prone head positioning in patients wit…
Rhegmatogenous retinal detachment (RRD) is an acute, sight threatening condition, with an incidence of approximately 10 per 100,000 people. Surgical interventio…
Patients with uncomplicated rhegmatogenous retinal detachment will be recruited. All eyes will underwent 23G PPV with silicon oil tamponade. The eyes will be cl…
This study is a first-in-human clinical trial testing a new treatment for rhegmatogenous retinal detachments. The new treatment called retinal thermofusion uses…
This study has two main objectives. The first objective is to study the pharmacokinetics of topical netarsudil administration in the posterior segment of the ey…
The objective of the study is to evaluate the efficacy of using hAM patches over the retina to seal inferior retinal breaks. The researchers will evaluate wheth…
Disease or general study area: Uncomplicated rhegmatogenous retinal detachment (RRD) and risk of proliferative vittroretinopathy (PVR) Purpose and nature of th…
The Tender Study is a prospective, open-label, single-center, randomized, investigator-initiated clinical study seeks to investigate the safety and efficacy of…
Rhegmatogenous retinal detachment (RRD) is a vision-threatening condition with an estimated incidence of approximately 1 in 10,000 individuals annually. Pars pl…